Literature DB >> 11477120

Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components.

T Watanabe1, Y Oda, S Tamiya, K Masuda, M Tsuneyoshi.   

Abstract

AIMS: To compare the expression of immunohistochemical variables between benign and malignant components of malignant peripheral nerve sheath tumour (MPNST) arising within neurofibroma.
METHODS: Eight cases of MPNST arising within a neurofibroma, associated with neurofibromatosis type 1 (NF1), were studied. The areas of MPNST and neurofibroma were compared immunohistochemically with regard to the expression of proliferative activity (MIB-1), growth factors, p53, bcl-2, neural cell adhesion molecule (N-CAM), and CD34.
RESULTS: The expression of transforming growth factor beta 1 (TGF-beta 1), TGF-beta receptor type II, hepatocyte growth factor alpha (HGF-alpha), c-met, p53, and N-CAM was higher in the areas of MPNST than in the neurofibromatous areas in four, five, five, eight, five, and three of the eight cases, respectively. CD34 expression was lower in the areas of MPNST than in the neurofibroma areas in three of the eight cases.
CONCLUSIONS: On the basis of these findings, TGF-beta 1, HGF-alpha, and p53 might be involved in the malignant transformation of neurofibroma to MPNST.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477120      PMCID: PMC1731495          DOI: 10.1136/jcp.54.8.631

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia.

Authors:  P A Eccleston; K Funa; C H Heldin
Journal:  Dev Biol       Date:  1993-02       Impact factor: 3.582

3.  The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma.

Authors:  B J Nickoloff
Journal:  Arch Dermatol       Date:  1991-04

4.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

Authors:  J E DeClue; A G Papageorge; J A Fletcher; S R Diehl; N Ratner; W C Vass; D R Lowy
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

5.  Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.

Authors:  E Legius; D A Marchuk; F S Collins; T W Glover
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

6.  Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis.

Authors:  D Schubert
Journal:  J Neurobiol       Date:  1992-03

7.  TGF beta signals through a heteromeric protein kinase receptor complex.

Authors:  J L Wrana; L Attisano; J Cárcamo; A Zentella; J Doody; M Laiho; X F Wang; J Massagué
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

8.  Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1).

Authors:  R A Lothe; G Saeter; H E Danielsen; A E Stenwig; B Høyheim; P O'Connell; A L Børresen
Journal:  Pathol Res Pract       Date:  1993-05       Impact factor: 3.250

9.  Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.

Authors:  M Miettinen; A E Lindenmayer; A Chaubal
Journal:  Mod Pathol       Date:  1994-01       Impact factor: 7.842

10.  Neural cell adhesion molecule distribution in soft tissue tumors.

Authors:  M Miettinen; W Cupo
Journal:  Hum Pathol       Date:  1993-01       Impact factor: 3.466

View more
  9 in total

1.  Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor.

Authors:  Q Fan; J Yang; G Wang
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

2.  Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Authors:  Helge R Brekke; Matthias Kolberg; Rolf I Skotheim; Kirsten S Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; Håvard E Danielsen; Fredrik Mertens; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2009-01-30       Impact factor: 12.300

3.  MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.

Authors:  Nikola Holtkamp; Isis Atallah; Ali-Fuat Okuducu; Jana Mucha; Christian Hartmann; Victor-F Mautner; Reinhard E Friedrich; Christian Mawrin; Andreas von Deimling
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

4.  Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.

Authors:  Eric P Rahrmann; Branden S Moriarity; George M Otto; Adrienne L Watson; Kwangmin Choi; Margaret H Collins; Margaret Wallace; Beau R Webber; Colleen L Forster; Anthony E Rizzardi; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Am J Pathol       Date:  2014-05-13       Impact factor: 4.307

Review 5.  How does the Schwann cell lineage form tumors in NF1?

Authors:  Steven L Carroll; Nancy Ratner
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

6.  Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells.

Authors:  Stacey L Thomas; George H De Vries
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 4.414

7.  Malignant peripheral nerve sheath tumor in neurobifromatosis type-1: two case reports.

Authors:  Christos Kosmas; George Tsakonas; Katerina Evgenidi; Argyris Gassiamis; Lefkothea Savva; Nikolaos Mylonakis; Athanasios Karabelis
Journal:  Cases J       Date:  2009-06-09

8.  Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.

Authors:  Jacqueline D Peacock; David Cherba; Kevin Kampfschulte; Mallory K Smith; Noel R Monks; Craig P Webb; Matthew Steensma
Journal:  J Transl Med       Date:  2013-09-17       Impact factor: 5.531

9.  TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.

Authors:  Gun-Hoo Park; Su-Jin Lee; Hyunee Yim; Jae-Ho Han; Hyon J Kim; Young-Bae Sohn; Jung Min Ko; Seon-Yong Jeong
Journal:  Oncol Rep       Date:  2014-08-04       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.